Home Visioneering Technologies Inc.: Redefining Vision NaturalVue® Multifocal Wins The Contact Lens Award for 2024

NaturalVue® Multifocal Wins The Contact Lens Award for 2024

The Contact Lens Award for NaturalVue featuring Maxine Green and Nick Atkins of Positive Impact, VTI’s Authorized Distributor In the United Kingdom

Visioneering Technologies, Inc. announces that NaturalVue® (etafilcon A) Multifocal 1 Day Contact Lenses, in partnership with its Authorized Distributor Positive Impact, has won The Contact Lens Award at the prestigious Optician Awards.

The Optician Awards celebrates excellence within the UK optical industry. With a legacy spanning over 30 years, these awards are among the most esteemed recognitions in British optics. The winners were unveiled on November 22 in London.

The Contact Lens Award honors products and companies that have made a significant impact in the contact lens market over the past year. Judged by a panel of UK-based contact lens specialists, this category evaluates each nominee based on their innovation, contribution to market growth, and success in real-world practices.

The win recognizes the unique role that NaturalVue® Multifocal lenses have played in advancing contact lens technology, along with its commitment to supporting eye care professionals and providing products that exceed customer expectations. The release of the Year 1 results from the 3-year PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue® Multifocal Contact Lens) was instrumental in this nomination, showcasing
our commitment to myopia management and improving the quality of life of patients. Dr. Juan Carlos Aragón, CEO and Executive Director of VTI, noted, “A special thanks to Positive Impact who put together an impressive and comprehensive submission for the award that among the highlights from our PROTECT study also included valuable feedback from NaturalVue fitters and patient experiences with the lenses. We are deeply
honored to receive this coveted award and thank our partners for being part of our journey to bring innovative vision solutions to life.”

The PROTECT study, a three-year, randomized, double-masked, controlled clinical trial, evaluates the safety and efficacy of NaturalVue Multifocal lenses for managing myopia progression in children—a crucial area in pediatric eye care.

MKT-VTI-PR89

Featured image: NaturalVue Multifocal – The Contact Lens Award 2024 and the Positive Impact Team, Courtesy of VTI.

 

Read other stories from Visioneering Technologies Inc. here

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

- Advertisment -

Most Popular

New Jersey Practice Pulls Inspiration From Iceland

It was always the goal of Talia Mishkin, OD, to open her own practice. She’d grown up watching her father manage a multi-location MD/OD...

American Optometric Association Secures Legislative Win

A new law will ease the burden of federal training and education requirements for doctors of optometry and expand access to and treatment of opioid use disorders—and specifically recognizes...

The Myopia Collective Urges Congress to Back Nation’s First Federally Funded Children’s Vision Health Program

Five members of The Myopia Collective, a joint initiative between the American Optometric Association (AOA) and CooperVision, met with lawmakers on Capitol Hill November...

Euro-Clean, Eye-Safe Beauty: An Inside Look at Eyederm and Its Founder

Learn more about Eyederm Cosmetics here. Listen to more WO Voices podcasts here. Would you like to be a guest on WO Voices? Contact us.